Week In Review: China's Life Science Deals Top $1.4 Billion For Week
August 19, 2017 at 15:57 PM EDT
Harbin Gloria Pharma and WuXi Biologics have entered an ex-China agreement for a PD-1 antibody with Arcus Biosciences of California's Bay Area in a deal worth up to $818 million.
